Big Pharma’s patent cliff sparks biotech deal rush
Big Pharma's $300 billion patent cliff is driving a biotech deal rush as drugmakers scramble to buy new pipelines. Discover the strategy behind the surge.
Read More →
Real Estate ETFs Beat Market Despite Rising Rates
Real estate ETFs outpace the market despite rising rates. Discover how funds like XLRE and VNQ beat the S&P 500.
Read More →
Investors flock to ETFs over mutual funds
Investors are shifting from mutual funds to ETFs for better flexibility and lower costs in 2026. Discover why this trend is reshaping wealth management.
Read More →
Easing Conflict Boosts Trade as Fed, Liquidity Risks Loom
Equity market rebound in 2026 driven by de-escalating geopolitical tensions and strong corporate earnings, boosting trade and investment opportunities.
Read More →
Dimensional broadens fixed income share class offerings
Dimensional Fund Advisors broadens fixed income ETF offerings with five new share classes for systematic bond strategies. Learn how this impacts investors.
Read More →
Treasury yields seen steady through 2026
Explore the steady growth of the lab-grown diamonds market, driven by demand for sustainable and affordable alternatives.
Read More →